600196.SS Insider activity — how to read the signals
Insider buying and selling is noisy — executives sell for taxes, diversification, and life events. But clusters of insider buying, or a sudden exodus, can be a signal. This page shows the 600196.SS insider research workflow.
Balance Labs = AI Stock Chat · Berkshire fundamentals desk · Screener timing (US/HK/A-share/KR/India) · Free 30 AI credits/mo
Fosun Pharma snapshot (2026-08-28)
| Snapshot | 2026-08-28 · source: tencent |
|---|---|
| Market | 600196.SS |
| Sector | Pharma |
| Last price | ¥22.84 |
| Signal | LONG · uPnL -3.6% |
| Total return | -1.8% |
What to check in insider filings
- Open-market purchases — CEO/CFO buying with personal cash is the strongest insider signal.
- Cluster buying — multiple insiders buying within days of each other is stronger than one.
- Option exercises vs open-market buys — only open-market purchases with personal cash count.
- Rule 10b5-1 plans — pre-scheduled sales are noise; discretionary sales are signal.
Sources: SEC EDGAR (US), HKEX disclosures (HK), exchange filing systems for A-share/KR/India.
Run the 600196.SS insider brief
Run the live brief — free
Stock Chat + Screener preview · 30 monthly AI credits · no card required. Covers US, HK, China A-share, Korea, India.
FAQ
Who are the major 600196.SS institutional holders?
Check the latest 13F filings on SEC EDGAR (for US stocks) or the exchange's institutional ownership disclosures. The Balance Labs 600196.SS brief tracks institutional quality as part of the fundamental assessment.
What does insider selling at Fosun Pharma mean?
Insider selling has many causes (taxes, diversification, estate planning) and is weak as a standalone signal. What matters more: is the CEO/CFO buying with their own money? Are multiple insiders buying simultaneously? Clusters of open-market buys are the stronger signal.
Should I follow insider trades on 600196.SS?
Use insider activity as one input, not the thesis. The Balance Labs workflow checks insider behaviour as a supporting data point within the broader quality and valuation assessment — never as a standalone buy/sell reason.
← All guides · Home · Not investment advice.